Abstract | AIM: METHODS:
Stanniocalcin 2 expression was determined by real-time PCR in 10 pairs of cervical cancer and adjacent normal cervical tissues. Tumor samples from 92 patients diagnosed from 2004 to 2007 were studied. All samples were obtained prior to treatment start. All cases were clinically diagnosed and pathologically confirmed to be cervical carcinoma without distant metastasis, and have been treated with radical radiation therapy and followed-up for five years. The samples were immunohistochemically analyzed for stanniocalcin 2 expression and survival analyses were performed. RESULTS: CONCLUSION:
|
Authors | Xiao-Jian Shen, Ke Gu, Jian-Ping Shi, Jian-Qin Yao, Jin-Chang Wu |
Journal | International journal of clinical and experimental pathology
(Int J Clin Exp Pathol)
Vol. 7
Issue 12
Pg. 8770-6
( 2014)
ISSN: 1936-2625 [Electronic] United States |
PMID | 25674244
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- Glycoproteins
- Intercellular Signaling Peptides and Proteins
- STC2 protein, human
- Cisplatin
|
Topics |
- Adult
- Aged
- Antineoplastic Agents
(administration & dosage)
- Biomarkers, Tumor
(analysis)
- Brachytherapy
(methods)
- Carcinoma
(mortality, pathology, radiotherapy)
- Chemoradiotherapy
- Cisplatin
(administration & dosage)
- Disease Progression
- Disease-Free Survival
- Female
- Glycoproteins
(biosynthesis)
- Humans
- Immunohistochemistry
- Intercellular Signaling Peptides and Proteins
(biosynthesis)
- Kaplan-Meier Estimate
- Lymphatic Metastasis
(pathology)
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Radiation Tolerance
(physiology)
- Radiotherapy, Conformal
- Real-Time Polymerase Chain Reaction
- Uterine Cervical Neoplasms
(mortality, pathology, radiotherapy)
|